Dihydroceramide (BioCAD00000020829)
{$topic}
Metabolite Card
Formula: C19H39NO3 (329.293)
SMILES: CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC=O
Synonyms [en]
Dihydroceramide; N-Acylsphinganine; N-[(2S,3R)-1,3-Dihydroxyoctadecan-2-yl]formamide; 3R)-1; Q63153308; 3-dihydroxyoctadecan-2-ylformamide
Last reviewed on 2024-06-28.
Cite this Page
Dihydroceramide. 数据之源,洞见之始. SMRUCC genomics institute, a synthetic life researcher from China.
https://biocad_registry.innovation.ac.cn/s/(-)-arctiin
(retrieved
2026-01-03) (CAD Registry RN: BioCAD00000020829). Licensed
under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).
Note
Dihydroceramide is an intermediate in sphingolipid metabolism. Dihydroceramide is the third to last step in the synthesis of beta-D-Galactosyl-1,4-beta-D glucosylceramide and is converted from sphinganine via the enzyme acyl-CoA-dependent ceramide synthase (EC 2.3.1.24). It is then converted to N-acylsphingosine via the enzyme fatty acid desaturase (EC 1.14.-.-).
DBLinks
- CAS Registry Number:
- PubChem CID: 16755624
- ChEBI: 31488
- HMDB: HMDB0006752
- LipidMaps:
- KEGG: C12126
- BioCyc:
- NCBI MeSH: dihydroceramide
- Wikipedia:
Other DBLinks
- PubChem: 16755624
- ChEBI: ChEBI:31488
- HMDB: HMDB0006752
- HMDB: HMDB06752
- KEGG: C12126
- NCBI MeSH: dihydroceramide
- Metlin: METLIN_58540
- Coconut NaturalProduct: CNP0154914.2
Class / Ontology
- WishartLab ClassyFire: [Carboxylic acid derivatives] Carboxylic acid derivatives
- Coconut NaturalProduct: [Sphingoid bases] Sphingoid bases
Taxonomy Source
Pathway Synthetic
| pathway id | name |
|---|---|
| BioCyc:YEAST_PWY-7119 | sphingolipid recycling and degradation (yeast) |
| BioCyc:FLY_PWY3DJ-12 | ceramide de novo biosynthesis |
| BioCyc:THAPS_PWY3DJ-12 | ceramide biosynthesis |
| BioCyc:ARA_PWY-5129 | sphingolipid biosynthesis (plants) |
| BioCyc:HUMAN_PWY3DJ-12 | ceramide de novo biosynthesis |
| BioCyc:META_PWY-7119 | sphingolipid recycling and degradation (yeast) |
| BioCyc:META_PWY-5129 | sphingolipid biosynthesis (plants) |
| BioCyc:MOUSE_PWY3DJ-12 | ceramide biosynthesis |
| BioCyc:META_PWY-7277 | sphingolipid biosynthesis (mammals) |
| BioCyc:META_PWY3DJ-12 | ceramide de novo biosynthesis |
| WikiPathways:WP1422 | Sphingolipid pathway |
| WikiPathways:WP3232 | Sphingolipid metabolism |
| WikiPathways:WP5194 | Synthesis of ceramides and 1-deoxyceramides |
| WikiPathways:WP4142 | Metabolism of sphingolipids in ER and Golgi apparatus |
| PathBank:SMP0120702 | Globoid Cell Leukodystrophy |
| PathBank:SMP0120738 | Metachromatic Leukodystrophy (MLD) |
| PathBank:SMP0120810 | Krabbe Disease |
| PathBank:SMP0000349 | Gaucher Disease |
| PathBank:SMP0002378 | Sphingolipid Metabolism |
| PathBank:SMP0087398 | Sphingolipid Metabolism |